Every era has had a resource that decided who held power. Coal decided the first industrial age. Oil decided the twentieth century, handing leverage to whoever controlled extraction and refining. Data decided the early internet age, building fortunes for the platforms that captured it first.
A new resource is emerging, and it sits inside the human skull.
Brain-computer interfaces do not just restore movement to paralysed patients or let a person type with their thoughts. At scale, they generate something no previous technology has produced: large, longitudinal records of how an individual brain actually works. That data, if it accumulates the way internet data once did, will decide who holds cognitive and strategic advantage for the rest of the century.
Three powers are already positioning for that outcome, and they are doing it in very different ways.
The United States: Speed as Strategy
The American approach to BCIs is private-sector first, and it shows. Neuralink, Synchron, and Blackrock Neurotech are not government programmes. They are venture-funded companies racing each other under a regulatory environment built to move fast, including sandboxes that allow human trials to begin sooner than in most other jurisdictions.
This produces real advantages. Capital moves quickly when it is chasing a frontier this large. Cultural tolerance for risk allows companies to attempt timelines that slower institutions would never approve. The result is a landscape where multiple well-funded actors are independently pushing the technology forward, each one trying to outpace the others.
It also creates a real weakness. Fragmentation across competing private actors means there is no unified national strategy tying these efforts together. Neuralink, Synchron, and Blackrock are not coordinating around a shared long-term goal. They are competing for the same prize, which sharpens innovation but leaves the United States without a single coherent answer to the question of where this is all supposed to lead.
China: Planning at National Scale
China’s approach inverts the American model entirely. Instead of letting private companies compete independently, neuroscience research is folded directly into national AI strategy, coordinated across state labs, universities, and private firms aligned toward a single set of goals.
This gives China two advantages that fragmented private markets cannot easily replicate. The first is scale: when state labs, universities, and companies are all pointed in the same direction, resources concentrate instead of dilute. The second is data access. A population the size of China’s, combined with far fewer constraints on data collection, creates conditions for amassing neural datasets faster than almost anywhere else on earth.
The tradeoff is transparency, and it is not a small one. Research pipelines coordinated by the state are largely invisible to international peer review, and the ethical frameworks governing this work diverge sharply from Western norms. That opacity limits China’s credibility as a global partner, even if it accelerates raw technical progress behind closed doors.
Europe: Betting on Trust
Europe is not trying to win the speed race, and it knows it. The Human Brain Project represents a different theory of competition entirely: deep, rigorous fundamental neuroscience paired with strong ethical oversight, aimed at producing standards the rest of the world eventually has to fall in line with.
This is a patient bet, and a risky one. Europe is positioned to write the rules of the game even if it never builds the fastest hardware. Foundational research and trusted governance are durable assets that outlast any single company’s product cycle. But durability only matters if the world is still waiting when Europe finishes writing the rulebook.
The cost is speed to market. Fragmented funding across member states slows coordination, and Europe’s commercialisation pathway lags significantly behind both the United States and China. Whether ethical leadership converts into real strategic leverage will depend on whether the rest of the world actually waits for Europe’s standards, or whether faster-moving rivals simply build the future first and dare regulators to catch up.
Why the Stack Matters More Than Any Single Layer
None of these national strategies plays out on a single battlefield. BCIs are built across four layers: hardware, signal processing, cognitive applications, and the neural data those layers generate. A country or company can dominate one layer and still lose the larger race if it fails to control the rest.
This is the real stakes of the contest. It is not about who builds the best implant. It is about who integrates hardware, AI decoding, applications, and data ownership into one coherent system first. The United States has hardware momentum. China has data scale and coordination. Europe has trust and standards. None of the three currently holds all four layers at once, which is the only reason this race is still open.
The Resource Question
Oil rewarded whoever controlled extraction and refining infrastructure. Internet-era data rewarded whoever built the platforms that captured it. Neural data will reward whoever builds the systems, hardware, AI models, and applications, that generate it at scale and keep generating it over time.
That makes it a different kind of resource than oil. It cannot be stockpiled in a reserve. It accumulates continuously, person by person, signal by signal, as more people use BCIs for longer stretches of their lives. Whoever has the most users generating the most data over the longest time ends up holding the largest dataset, and the largest dataset trains the best decoding models, which attracts even more users. The advantage compounds, and it compounds fast.
This is why the current moment matters more than it looks like it should. Early leads, in hardware deployment, in user adoption, in raw data accumulation, may be nearly impossible to dislodge later, even for a rival with objectively better technology. First-mover advantage in a compounding data resource is not the same as first-mover advantage in a product market. It is closer to what made early internet platforms unkillable once they hit scale.
Where This Leaves Everyone Else
The United States, China, and Europe are not the only ones with a stake in this outcome. A wide tier of countries, India among them, is watching this race from outside the frontier, deciding whether and how to force its way in.
That decision, what a country with strong software talent, a competitive biotech base, and a population this size can realistically contribute to a race already being run by three well-resourced powers, is the subject of the next piece in this series.
